Swiss Hospitality Stock News

Roche’s new cobas MPX-E assay and why it matters for shareholders Roche Holding (SWX:ROG) has launched its cobas MPX-E multiplex assay in CE mark countries, offering simultaneous screening for HIV, HCV, HBV and HEV on existing cobas x800 systems to support higher throughput donor testing. See our latest analysis for Roche Holding. Roche’s share price has softened recently, with a 30 day share price return of 10.47% and a year to date share price return of a 0.98% decline, even though the 1...

As European markets experience a positive shift, with the STOXX Europe 600 Index gaining 3.92% amid hopes for a shorter-lived Middle East conflict, investors are keenly observing how energy market volatility and inflation trends might impact dividend stocks. In this context, selecting robust dividend stocks involves considering companies with strong financial health and stable cash flows that can weather economic fluctuations while continuing to provide reliable income streams.

Dividend announcement puts yield in focus for BCGE Banque Cantonale de Genève (SWX:BCGE) has announced an annual dividend of CHF 0.5250 per share, with the stock trading ex dividend on 5 May 2026 and payment scheduled for 7 May 2026. See our latest analysis for Banque Cantonale de Genève. The dividend news follows a strong run in the shares, with a 30 day share price return of 12.38% and a 90 day share price return of 40.48%. The 1 year total shareholder return of 48.30% highlights how...

If you are wondering whether UBS Group's current share price reflects its true worth, you are not alone. That is exactly what this article is here to unpack. UBS Group closed at CHF31.16 recently, with returns of 1.4% over the past 7 days, 4.4% over the past 30 days, a year to date return of negative 18.4%, 39.6% over 1 year, 79.1% over 3 years and 141.6% over 5 years, hinting at shifting expectations around both opportunity and risk. Recent coverage has focused on UBS Group's ongoing...

Wondering if Logitech International at around $73.32 is offering genuine value or just riding sentiment? This article breaks down what the current share price might be implying about the business. The stock has returned 1.3% over the last 7 days and 4.6% over the last 30 days, set against a year to date return of a 7.8% decline and a 25.7% return over 1 year, with a 49.7% return over 3 years and a 21.4% decline over 5 years. Recent coverage has focused on Logitech International as an...

Investors were underwhelmed by the solid earnings posted by SoftwareOne Holding AG ( VTX:SWON ) recently. Our analysis...

If you are wondering whether Novartis at around CHF123 per share still offers value, the key is to look past the headline price and focus on what you are actually getting for each franc invested. The stock has returned 1.9% over the last week, is roughly flat over 30 days, and has delivered 13.5% year to date alongside 43.2% over 1 year, 65.7% over 3 years, and 96.0% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent attention...

Why Nestlé (SWX:NESN) is on investors’ radar today Nestlé (SWX:NESN) continues to attract attention as investors reassess large consumer staples groups, with the share price around CHF 78.37 and recent returns mixed across the past month and past 3 months. See our latest analysis for Nestlé. While the share price is around CHF78.37 with a 90 day share price return of 2.90%, the 1 year total shareholder return of 2.91% decline and 3 year total shareholder return of 24.37% decline point to...

Roche Holding (SWX:ROP) has attracted fresh attention after announcing the cobas MPX-E assay, a CE-marked in vitro test that screens for HIV and multiple hepatitis viruses in a single high-throughput run. See our latest analysis for Roche Holding. Roche’s recent diagnostics launches and R&D investment news arrive while the share price sits at CHF318.0, with a 30 day share price return of a 6.8% decline but a 1 year total shareholder return of 33.17% that points to stronger long term...

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite have shown resilience with notable gains, reflecting a cautiously optimistic sentiment amid geopolitical uncertainties. In such an environment, growth companies with significant insider ownership often attract attention due to their potential for alignment between management and shareholder interests, which can be particularly appealing when navigating...

As European markets navigate through the complexities of Middle East tensions and energy market volatility, recent gains in indices like the STOXX Europe 600 and Germany’s DAX suggest a cautiously optimistic sentiment among investors. In such an environment, identifying stocks that may be priced below their intrinsic value can offer potential opportunities for those looking to capitalize on market inefficiencies.

As European markets show resilience with the STOXX Europe 600 Index rising by 3.92%, investor sentiment is buoyed by hopes of a shorter-than-expected Middle East conflict and robust gains in major indices like Germany’s DAX and the UK’s FTSE 100. In this environment, growth companies with high insider ownership can offer unique opportunities, as they often signal strong confidence from those closest to the business, aligning their interests with shareholders during volatile times.

What the latest earnings mean for Aevis Victoria Aevis Victoria (SWX:AEVS) has drawn investor attention after releasing full year 2025 results, with higher sales and revenue reported alongside a materially larger net loss and wider loss per share. The company reported sales of CHF 1,132.9 million and revenue of CHF 1,055.06 million for the year ended December 31, 2025. At the same time, Aevis Victoria posted a net loss of CHF 20.11 million, with basic and diluted loss per share from...

Swiss Prime Site (SWX:SPSN) has moved after the company appointed Martina Moosmann as Chief Financial Officer, formalising succession after an interim period and providing investors with fresh information about its senior financial leadership. See our latest analysis for Swiss Prime Site. The appointment appears to have sparked fresh interest, with the share price at CHF138.4 after a 1 day share price return of 1.10% and 7 day share price return of 4.93%. A 90 day share price return of 13.07%...

Why Swisscom’s tower plans are back in focus Swisscom (SWX:SCMN) recently held a shareholder and analyst call to lay out its perspective on a tower development initiative, putting the economics of its telecom infrastructure and potential use of towers on investors’ radar. See our latest analysis for Swisscom. At a share price of CHF671.5, Swisscom’s recent tower update comes after a 15.98% year to date share price return and a 34.67% total shareholder return over 1 year, suggesting that...

Avolta (SWX:AVOL) has drawn investor attention after securing a new 15 year food and beverage contract at Jacksonville International Airport in the US, alongside continued expansion of its integrated travel retail model across Latin America. See our latest analysis for Avolta. Recent contract wins at Jacksonville and the continued rollout of the integrated airport model in Latin America have come alongside a CHF49.64 share price, a 6.1% year-to-date share price return and a 47.7% total...

Readers hoping to buy Forbo Holding AG ( VTX:FORN ) for its dividend will need to make their move shortly, as the stock...

Readers hoping to buy Meier Tobler Group AG ( VTX:MTG ) for its dividend will need to make their move shortly, as the...

Intro Aevis Victoria (SWX:AEVS) has put fresh numbers on the table for FY 2025, with first half revenue of CHF 535.9 million and basic EPS of CHF 0.049, following CHF 420.0 million of revenue and a basic EPS loss of CHF 0.025 in the second half of FY 2024. Over the last three reported half year periods, revenue has moved from CHF 463.1 million in the first half of FY 2024 to CHF 420.0 million in the second half of FY 2024 and then to CHF 535.9 million in the first half of FY 2025. Over the...

Montana Aerospace (SWX:AERO) FY 2025 Earnings Snapshot Montana Aerospace (SWX:AERO) just posted its FY 2025 numbers with third quarter revenue at €256.2 million and basic EPS of €0.10, alongside net income from continuing operations of €6.1 million. The trailing twelve month view shows revenue of €1.6 billion and basic EPS of €0.49, which helps frame the bigger picture. Over recent periods, the company has reported revenue moving from €389.8 million in Q4 2023 to €440.3 million in Q4 2024 and...

ABB (SWX:ABBN) has drawn attention after its recent share performance, with a roughly 2% decline over the past month contrasted with a gain of about 11% over the past 3 months. See our latest analysis for ABB. At a share price of CHF65.84, ABB’s recent 2% one month share price decline contrasts with its 11% three month share price return and a 1 year total shareholder return of about 56%. This suggests momentum has been broadly positive even if short term sentiment has cooled. If you want to...

Roche Holding (SWX:ROP) has received CE marking for its cobas MPX-E assay, enabling simultaneous screening for HIV, hepatitis C, B, and E in blood donations. The company has also launched the cobas eplex RP3 respiratory panel, designed to test for up to 25 respiratory pathogens in a single rapid assay. These diagnostics products target blood safety, laboratory efficiency, and faster respiratory infection diagnosis across clinical settings. Roche Holding, trading at around CHF318.0,...

Amrize (SWX:AMRZ) has completed the acquisition of PB Materials Holdings, adding 26 locations across West Texas. The move increases Amrize’s presence in a region with significant infrastructure and energy related project activity. The transaction reflects Amrize’s push to grow business lines that are less tied to the residential construction cycle. Amrize, listed as SWX:AMRZ, now trades at CHF43.64 per share, with the stock showing a 0.8% decline over the past week and a 1.9% decline year...

Partners Group Holding (SWX:PGHN) has appointed Pete Zippelius as Co-Head of its Private Equity Health & Life vertical, sharpening its focus on healthcare and life sciences. The firm is also reported to be in early discussions to acquire a significant stake in Happiest Minds Technologies alongside other private equity investors. Partners Group Holding, trading at around CHF866.0, has seen mixed share performance, with a 4.2% gain over the past week and 5.6% over the past month, set against...